The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Structure of the p53 Core Domain Dimer Bound to DNA
Abstract
The p53 tumor suppressor protein binds to DNA as a dimer of dimers to regulate transcription of genes that mediate responses to cellular stress. We have prepared a cross-linked trapped p53 core domain dimer bound to decamer DNA and have determined its structure by x-ray crystallography to 2.3A resolution. The p53 core domain subunits bind nearly symmetrically to opposite faces of the DNA in a head-to-head fashion with a loophelix motif making sequence-specific DNA contacts and bending the DNA by about 20 degrees at the site of protein dimerization. Protein subunit interactions occur over the central DNA minor groove and involve residues from a zinc-binding region. Analysis of tumor derived p53 mutations reveals that the dimerization interface represents a third hot spot for mutation that also includes residues associated with DNA contact and protein stability. Residues associated with p53 dimer formation on DNA are poorly conserved in the p63 and p73 paralogs, possibly contributing to their functional differences. We have used the dimeric protein-DNA complex to model a dimer of p53 dimers bound to icosamer DNA that is consistent with solution bending data and suggests that p53 core domain dimer-dimer contacts are less frequently mutated in human cancer than intra-dimer contacts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p53 binds to a full consensus DNA response element as a tetramer through a highly cooperative self-assembling mechanism (Fig. 7b).”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [297]
In the citing paper
“Two DBDs bind each decameric half-site as a symmetrical dimer (A-B), and two such dimers (A-B and C-D) constitute a tetramer on a full DNA response element via protein-protein and base stacking interactions.11,70,295–299”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [297]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,551
Definition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
A Global Map of p53 Transcription-Factor Binding Sites in the Human Genome
Wei, C.-L., Wu, Q., Vega, V. B., Chiu, K. P., Ng, P., Zhang, T., Shahab, A., Yong, H. C., Fu, Y., Weng, Z., et al. (2006) · Cell · doi:10.1016/j.cell.2005.10.043 · Cited by 1,141
Research works printed but not linked: 39
- Vousden, 2002, Nat. Rev. Cancer, 2, 594, 10.1038/nrc864 · DOI · Paper page
- Weinberg, 2004, J. Mol. Biol., 341, 1145, 10.1016/j.jmb.2004.06.071 · DOI · Paper page
- Jeffrey, 1995, Science, 267, 1498, 10.1126/science.7878469 · DOI · Paper page
- Clore, 1995, Nat. Struct. Biol., 2, 321, 10.1038/nsb0495-321 · DOI · Paper page
- Pavletich, 1993, Gene Dev., 7, 2556, 10.1101/gad.7.12b.2556 · DOI · Paper page
- Wang, 1993, Genes Dev., 7, 2575, 10.1101/gad.7.12b.2575 · DOI · Paper page
- Balagurumoorthy, 1995, Proc. Natl. Acad. Sci. U. S. A., 92, 8591, 10.1073/pnas.92.19.8591 · DOI
- Wang, 1995, Mol. Cell. Biol., 15, 2157, 10.1128/MCB.15.4.2157 · DOI
- Hupp, 1994, Curr. Biol., 4, 865, 10.1016/S0960-9822(00)00195-0 · DOI · Paper page
- Halazonetis, 1993, EMBO J., 12, 5057, 10.1002/j.1460-2075.1993.tb06199.x · DOI · Paper page
- Waterman, 1995, EMBO J., 14, 512, 10.1002/j.1460-2075.1995.tb07027.x · DOI
- Zhao, 2001, J. Biol. Chem., 276, 12120, 10.1074/jbc.M011644200 · DOI
- Pietenpol, 1994, P. Natl. Acad. Sci. U. S. A., 91, 1998, 10.1073/pnas.91.6.1998 · DOI · Paper page
- Rippin, 2002, J. Mol. Biol., 319, 351, 10.1016/S0022-2836(02)00326-1 · DOI · Paper page
- Nagaich, 1997, J. Biol. Chem., 272, 14830, 10.1074/jbc.272.23.14830 · DOI
- Ma, 2005, Proc. Natl. Acad. Sci. U. S. A., 102, 3988, 10.1073/pnas.0500215102 · DOI
- Lebrun, 2001, Protein Eng., 14, 233, 10.1093/protein/14.4.233 · DOI
- Klein, 2001, J. Biol. Chem., 276, 49020, 10.1074/jbc.M107516200 · DOI · Paper page
- Dehner, 2005, Angew. Chem. Int. Ed. Engl., 44, 5247, 10.1002/anie.200501887 · DOI
- Huang, 2000, Biol. Chem., 7, 355, 10.1016/S1074-5521(00)00113-7 · DOI
- Huang, 1998, Science, 282, 1669, 10.1126/science.282.5394.1669 · DOI · Paper page
- Xu, 1992, J. Org. Chem., 57, 3839, 10.1021/jo00040a024 · DOI
- MacMillan, 1991, Tetrahedron, 47, 2603, 10.1016/S0040-4020(01)81793-2 · DOI
- Macmillan, 1990, J. Org. Chem., 55, 5931, 10.1021/jo00311a005 · doi:10.1021/jo00311a005
- Vagin, 1997, J. Appl. Crystallogr., 30, 1022, 10.1107/S0021889897006766 · DOI · Paper page
- Otwinowski, 1997, Methods Enzymol., 276, 307, 10.1016/S0076-6879(97)76066-X · DOI · Paper page
- Brunger, 1998, Acta Crystallogr. Sect. D Biol. Crystallogr., 54, 905, 10.1107/S0907444998003254 · DOI · Paper page
- Emsley, 2004, Acta Crystallogr. Sect. D Biol. Crystallogr., 60, 2126, 10.1107/S0907444904019158 · DOI · Paper page
- Jones, 1991, Acta Crystallogr. Sect. A, 47, 110, 10.1107/S0108767390010224 · DOI · Paper page
- Laskowski, 1993, J Appl. Crystallogr., 26, 283, 10.1107/S0021889892009944 · DOI · Paper page
- Lu, 2003, Nucleic Acids Res., 31, 5108, 10.1093/nar/gkg680 · DOI · Paper page
- Joerger, 2005, J. Biol. Chem., 280, 16030, 10.1074/jbc.M500179200 · DOI · Paper page
- Joerger, 2004, J. Biol. Chem., 279, 1291, 10.1074/jbc.M309732200 · DOI · Paper page
- Huyen, 2004, Structure (Camb.), 12, 1237, 10.1016/j.str.2004.05.007 · DOI
- Rainwater, 1995, Mol. Cell. Biol., 15, 3892, 10.1128/MCB.15.7.3892 · DOI · Paper page
- Yang, 1998, Mol. Cell, 2, 305, 10.1016/S1097-2765(00)80275-0 · DOI · Paper page
- Schmale, 1997, Oncogene, 15, 1363, 10.1038/sj.onc.1201500 · DOI · Paper page
- Klein, 2001, J. Biol. Chem., 276, 37390, 10.1074/jbc.M103801200 · DOI
- Nagaich, 1999, Proc. Natl. Acad. Sci. U. S. A., 96, 1875, 10.1073/pnas.96.5.1875 · DOI
Cited by
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
Principles of Protein−Protein Interactions: What are the Preferred Ways For Proteins To Interact?
Keskin, O., Gursoy, A., Ma, B., & Nussinov, R. (2008) · Chemical Reviews · doi:10.1021/cr040409x · Cited by 697
Structural Biology of the Tumor Suppressor p53
Joerger, A. C., & Fersht, A. R. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.060806.091238 · Cited by 693
The expanding universe of p53 targets
Menendez, D., Inga, A., & Resnick, M. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2730 · Cited by 568
Metadata
- Authors
- Ho, W. C., Fitzgerald, M. X., & Marmorstein, R.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-07
- Volume
- 281
- Issue
- 29
- Pages
- 20494-20502
- ISSN
- 0021-9258
- Cited by
- 118
- References
- 3
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5213 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.